Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension study of retigabine in adult patients with partial-onset seizures
2006-000956-42Phase 3Terminated
- Sponsor
- Bausch Health
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of retigabine in epilepsy, sponsored by Bausch Health. Primary endpoints: Percentage change in monthly total seizure rate, Percentage change in monthly total partial seizure rate and 1 more. Started Apr 2006; status: terminated.
02
Drugs
retigabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-000956-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000956-42.